Shortage of TB drugs in India – a major producer of these drugs

An article in the Wall Street Journal (June 6,2013) describes severe shortages of tuberculosis (TB) drugs in India, a country that is a major producer of TB drugs. TB kills a significant number of Indians and the government has been providing free treatment to eradicate the disease. But the expiration of a UK grant to pay for the drugs, and delays in government issue of required purchase orders, are supposed to have created the observed shortages. But drug manufacturers claim that poor forecasting and erratic orders are the cause of the observed shortages. Also, erratic use of the drug increases the drug resistance of the disease and makes treatment difficult. Low margins, poor supply chain management and poor forecasting are claimed to be causes. Should margins be increased to incent greater availability ? Should the forecasting of requirements be a private industry function with appropriate incentives for more accurate demand estimates ? Should vendor managed inventory contracts be provided to manufacturers to get them to maintain adequate supply ?

Advertisements

About aviyer2010

Professor
This entry was posted in Global Contexts, Operations Management, Supply Chain Issues and tagged , , , , , , , , , . Bookmark the permalink.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s